Your browser doesn't support javascript.
loading
Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients.
Ali, H R; Provenzano, E; Dawson, S-J; Blows, F M; Liu, B; Shah, M; Earl, H M; Poole, C J; Hiller, L; Dunn, J A; Bowden, S J; Twelves, C; Bartlett, J M S; Mahmoud, S M A; Rakha, E; Ellis, I O; Liu, S; Gao, D; Nielsen, T O; Pharoah, P D P; Caldas, C.
Afiliação
  • Ali HR; Cancer Research UK Cambridge Institute Departments of Pathology Oncology, University of Cambridge, Cambridge.
  • Provenzano E; Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge.
  • Dawson SJ; Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge.
  • Blows FM; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge.
  • Liu B; Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge.
  • Shah M; Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge Strangeways Research Laboratory, Cambridge.
  • Earl HM; Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge.
  • Poole CJ; Warwick Clinical Trials Unit, University of Warwick, Coventry.
  • Hiller L; Warwick Clinical Trials Unit, University of Warwick, Coventry.
  • Dunn JA; Warwick Clinical Trials Unit, University of Warwick, Coventry.
  • Bowden SJ; Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, The University of Birmingham, Birmingham.
  • Twelves C; University of Leeds and Leeds Cancer Research UK Centre, St James' Institute of Oncology, Leeds, UK.
  • Bartlett JM; Ontario Institute for Cancer Research, Toronto, Canada and Biomarker and Companion Diagnostics, Edinburgh Cancer Research Centre, Edinburgh Department of Histopathology and School of Molecular Medical Sciences, The University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, U
  • Mahmoud SM; Department of Pathology and Laboratory Medicine, University of British Columbia; Integrative Oncology Department, British Columbia Cancer Agency, Vancouver.
  • Rakha E; Department of Pathology and Laboratory Medicine, University of British Columbia; Integrative Oncology Department, British Columbia Cancer Agency, Vancouver.
  • Ellis IO; Department of Pathology and Laboratory Medicine, University of British Columbia; Integrative Oncology Department, British Columbia Cancer Agency, Vancouver.
  • Liu S; Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
  • Gao D; Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
  • Nielsen TO; Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
  • Pharoah PD; Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge Strangeways Research Laboratory, Cambridge.
  • Caldas C; Cancer Research UK Cambridge Institute Oncology, University of Cambridge, Cambridge Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge carlos.caldas@cruk.cam.ac.uk.
Ann Oncol ; 25(8): 1536-43, 2014 Aug.
Article em En | MEDLINE | ID: mdl-24915873

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Linfócitos do Interstício Tumoral / Linfócitos T CD8-Positivos Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Linfócitos do Interstício Tumoral / Linfócitos T CD8-Positivos Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article